tiprankstipranks
Sigma Healthcare Ltd (SGMFF)
OTHER OTC:SGMFF

Sigma Healthcare Ltd (SGMFF) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

SGMFF Analyst Ratings

Hold
4Ratings
0 Buy
3 Hold
1 Sell
Based on 4 analysts giving stock ratings to
Sigma
Healthcare Ltd
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

SGMFF Stock 12 Month Forecast

Average Price Target

Based on 4 Wall Street analysts offering 12 month price targets for Sigma Healthcare Ltd in the last 3 months. The average price target is $0.58 with a high forecast of $0.62 and a low forecast of $0.52. The average price target represents a change from the last price of .
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"plus_tr_sans","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"$0","1":"$1","-1":"-$1","-0.5":"-$0.5","0.5":"$0.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":0.6180288745822157,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n  <span style=\"color:#199ca5\">$0.62</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":0.5783336208,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n  <span style=\"color:#828080\">$0.58</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":0.5150240621518464,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n  <span style=\"color:#912767\">$0.52</span>\n  </div></div>","useHTML":true}}],"tickPositions":[-1,-0.5,0,0.5,1],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Mar<br/>2023","6":"Jun<br/>2023","9":"Sep<br/>2023","12":"Dec<br/>2023","25":"Dec<br/>2024"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.4,0.41677145189093967,0.4335429037818794,0.450314355672819,0.46708580756375867,0.4838572594546984,0.500628711345638,0.5174001632365777,0.5341716151275173,0.550943067018457,0.5677145189093966,0.5844859708003364,0.601257422691276,{"y":0.6180288745822157,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.4,0.4137179708307692,0.4274359416615385,0.4411539124923077,0.45487188332307693,0.46858985415384613,0.4823078249846154,0.4960257958153846,0.5097437666461538,0.523461737476923,0.5371797083076922,0.5508976791384614,0.5646156499692307,{"y":0.5783336208,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.4,0.40884800478091127,0.4176960095618225,0.4265440143427338,0.43539201912364506,0.4442400239045563,0.45308802868546755,0.4619360334663788,0.4707840382472901,0.47963204302820134,0.4884800478091126,0.4973280525900239,0.5061760573709351,{"y":0.5150240621518464,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":0.575,"date":1667260800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.575,"date":1669852800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.575,"date":1671753600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.575,"date":1679616000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":0.575,"date":1680825600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":0.575,"date":1683244800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.575,"date":1685664000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.575,"date":1688688000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":0.575,"date":1691107200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":0.575,"date":1693526400000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":0.575,"date":1696550400000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":0.575,"date":1698969600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":0.4,"date":1701388800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$0.62Average Price Target$0.58Lowest Price Target$0.52
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bank of America Securities
$0.58
Hold
Upgraded
06/07/23
BofA Securities Upgrades Sigma Healthcare Ltd. (SIG:AU) to NeutralBofA Securities analyst Lyanne Harrison upgraded Sigma Healthcare Ltd. (SIG:AU) from Underperform to Neutral with a price target of AUD0.85 (from AUD0.55).
Citi
$0.36
Sell
Reiterated
04/18/23
Citi Reiterates Sell Rating on Sigma Healthcare Ltd. (SIG:AU)Citi analyst John Deakin-Bell reiterated a Sell rating and AUD0.52 price target on Sigma Healthcare Ltd. (SIG:AU).
Ord Minnett Analyst forecast on SGMFF
Unknown Analyst
Not Ranked
Ord Minnett
$0.55
Hold
Reiterated
09/22/23

Best Analysts Covering Sigma Healthcare Ltd

Which Analyst Should I Follow If I Want to Buy SGMFF and Sell After:
1 Month
Ross CurranMacquarie
Success Rate
1/1 ratings generated profit
100%
Average Return
+0.80%
reiterated a sell rating 4 months ago
Copying Ross Curran's trades and holding each position for 1 Month would result in 100.00% of your transactions generating a profit, with an average return of +0.80% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
3 Months
Ross CurranMacquarie
Success Rate
1/1 ratings generated profit
100%
Average Return
+0.80%
reiterated a sell rating 4 months ago
Copying Ross Curran's trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +0.80% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
1 Year
Success Rate
1/2 ratings generated profit
50%
Average Return
-21.65%
reiterated a sell rating a year ago
Copying John Deakin-Bell's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of -21.65% per trade.
2 Years
Success Rate
0/2 ratings generated profit
0%
Average Return
-41.60%
reiterated a sell rating a year ago
Copying John Deakin-Bell's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -41.60% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

SGMFF Analyst Recommendation Trends

Rating
Jun 23
Jul 23
Sep 23
Oct 23
Dec 23
Strong Buy
1
1
1
0
0
Buy
0
0
0
0
0
Hold
7
8
8
4
6
Sell
3
0
0
0
1
Strong Sell
0
0
0
0
0
total
11
9
9
4
7
In the current month, SGMFF has received 0 Buy Ratings, 6 Hold Ratings, and 1 Sell Ratings. SGMFF average Analyst price target in the past 3 months is $0.58.
Each month's total comprises the sum of three months' worth of ratings.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

SGMFF Financial Forecast

SGMFF Earnings Forecast

Next quarter’s earnings estimate for SGMFF is <$0.01 with a range of <$0.01 to <$0.01. The previous quarter’s EPS was <$0.01. SGMFF beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.69% of the time in the same period. In the last calendar year SGMFF has Underperformed its overall industry.
Next quarter’s earnings estimate for SGMFF is <$0.01 with a range of <$0.01 to <$0.01. The previous quarter’s EPS was <$0.01. SGMFF beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.69% of the time in the same period. In the last calendar year SGMFF has Underperformed its overall industry.

SGMFF Sales Forecast

Next quarter’s sales forecast for SGMFF is $1.21B with a range of $1.21B to $1.21B. The previous quarter’s sales results were $1.16B. SGMFF beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 46.57% of the time in the same period. In the last calendar year SGMFF has Outperformed its overall industry.
Next quarter’s sales forecast for SGMFF is $1.21B with a range of $1.21B to $1.21B. The previous quarter’s sales results were $1.16B. SGMFF beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 46.57% of the time in the same period. In the last calendar year SGMFF has Outperformed its overall industry.

SGMFF Stock Forecast FAQ

What is SGMFF’s average 12-month price target, according to analysts?
Based on analyst ratings, Sigma Healthcare Ltd’s 12-month average price target is $0.58.
    What is SGMFF’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for SGMFF, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is SGMFF a Buy, Sell or Hold?
        Sigma Healthcare Ltd has a conensus rating of Hold which is based on 0 buy ratings, 3 hold ratings and 1 sell ratings.
          What is Sigma Healthcare Ltd’s price target?
          The average price target for Sigma Healthcare Ltd is $0.58. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst price target is $0.62 ,the lowest forecast is $0.52. The average price target represents N/A Increase from the current price of N/A.
            What do analysts say about Sigma Healthcare Ltd?
            Sigma Healthcare Ltd’s analyst rating consensus is a Hold. This is based on the ratings of 4 Wall Streets Analysts.
              How can I buy shares of SGMFF?
              Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis